The SK-N-AS human neuroblastoma cell line develops osteolytic bone metastases with increased angiogenesis and COX-2 expression

The SK-N-AS human neuroblastoma cell line develops osteolytic bone metastases with increased angiogenesis and COX-2 expression

Neuroblastoma (NB), which arises from embryonic neural crest cells, is the most common extra-cranial solid tumor of childhood. Approximately half of NB patients manifest bone metastasis accompanied with bone pain, fractures and bone marrow failure, leading to disturbed quality of life and poor survi...

Full description

Bibliographic Details
Main Authors:	Takahiro Tsutsumimoto, Paul Williams, Toshiyuki Yoneda
Format:	Article
Language:	English
Published:	Elsevier 2014-11-01
Series:	Journal of Bone Oncology
Subjects:	Osteoclasts Receptor activator of NF-κB ligand Vascular endothelial growth factor-A Microvessel density Adrenal gland COX-2 inhibitor
Online Access:	http://www.sciencedirect.com/science/article/pii/S221213741420008X

Similar Items

An insight in to Paget′s disease of bone
by: Robin Sabharwal, et al.
Published: (2014-01-01)

Up-regulation of COX-2/PGE<sub>2</sub> by endothelin-1 via MAPK-dependent NF-κB pathway in mouse brain microvascular endothelial cells
by: Lin Chih-Chung, et al.
Published: (2013-01-01)

Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway
by: Yulin Peng, et al.
Published: (2018-10-01)

Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-κB suppression
by: Patumraj S, et al.
Published: (2010-12-01)

Isoalantolactone inhibits IKKβ kinase activity to interrupt the NF‐κB/COX‐2‐mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma
by: Jin‐Shan Xing, et al.
Published: (2019-04-01)

RANKL/RANK/osteoprotegerin system as novel therapeutic target in the treatment of primary bone tumors and osteolytic metastases
by: Anđelković Zlatibor, et al.
Published: (2004-01-01)

Yan-Hou-Qing formula attenuates ammonia-induced acute pharyngitis in rats via inhibition of NF-κB and COX-2
by: Min Xu, et al.
Published: (2020-09-01)

Corrigendum: Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation
by: Zhe-Kun Jia, et al.
Published: (2020-11-01)

Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation
by: Zhe-Kun Jia, et al.
Published: (2018-02-01)

Analysis of Role of Angiogenesis in Epithelial Dysplasia: An Immunohistochemical Study
by: Sonia Gupta, et al.
Published: (2017-12-01)

Effects of Tea Polyphenols on the Expression of NF-κB, COX-2 and Survivin  in Lewis Lung Carcinoma Xenografts in C57BL/6 Mice
by: Jing WANG, et al.
Published: (2012-05-01)

Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways
by: Li X, et al.
Published: (2021-01-01)

Diphlorethohydroxycarmalol from Ishige okamurae Suppresses Osteoclast Differentiation by Downregulating the NF-κB Signaling Pathway
by: Hye Jung Ihn, et al.
Published: (2017-12-01)

Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity
by: Libo Zhao, et al.
Published: (2017-12-01)

Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo
by: Cong Cai, et al.
Published: (2018-11-01)

A Novel Small Molecule Which Increases Osteoprotegerin Expression and Protects Against Ovariectomy-Related Bone Loss in Rats
by: Xiaowan Han, et al.
Published: (2019-03-01)

Inhibitory effects of ChondroT and its constituent herbs on RANKL-induced osteoclastogenesis
by: Rui Hong Guo, et al.
Published: (2019-11-01)

Insulin-like growth factor 2 promotes osteoclastogenesis increasing inflammatory cytokine levels under hypoxia
by: Aoki, H., et al.
Published: (2022)

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT
by: Guoju Hong, et al.
Published: (2017-01-01)

Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling Pathways
by: Mengbo Zhu, et al.
Published: (2021-09-01)

Total flavonoids from celery suppresses RANKL-induced osteoclast differentiation and bone resorption function via attenuating NF-κB and p38 pathways in RAW264.7 cells
by: Lujuan Jia, et al.
Published: (2020-06-01)

Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
by: Xue Yang, et al.
Published: (2021-06-01)

Brazilian medicinal plants with corroborated anti-inflammatory activities: a review
by: Victor Pena Ribeiro, et al.
Published: (2018-01-01)

ADRENALECTOMY FOR ISOLATED METASTASES
by: Svetlana Shumarova, et al.
Published: (2017-08-01)

The significance of angiogenesis in tumorigenesis and prognosis of prostate cancer
by: I. I. Yakovtcova, et al.
Published: (2017-08-01)

Effect and molecular mechanism of isorhamnetin extracted from Ginkgo biloba on the differentiation of RAW264.7 cells into osteoclasts
by: LI Jing, et al.
Published: (2018-03-01)

Inhibiting Monoacylglycerol Lipase Suppresses RANKL-Induced Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
by: Hui Liu, et al.
Published: (2021-03-01)

Hiperplasia endotelial papilífera de supra-renal: relato de caso
by: Aissar E Nassif, et al.

A New Ligustrazine Derivative-Selective Cytotoxicity by Suppression of NF-κB/p65 and COX-2 Expression on Human Hepatoma Cells. Part 3
by: Chenze Zhang, et al.
Published: (2015-07-01)

Curcumin potentiates the potent antitumor activity of ACNU against glioblastoma by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathways
by: Zhao J, et al.
Published: (2017-11-01)

The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
by: Woong Gil Choi, et al.
Published: (2021-03-01)

Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
by: Xiaozhong Liao, et al.
Published: (2020-09-01)

Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
by: Xiaozhong Liao, et al.
Published: (2021-04-01)

Rubidium Chloride Targets Jnk/p38-Mediated NF-κB Activation to Attenuate Osteoclastogenesis and Facilitate Osteoblastogenesis
by: Zhengxiao Ouyang, et al.
Published: (2019-05-01)

Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
by: Jun-ming Huang, et al.
Published: (2018-09-01)

Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation
by: Zi’ang Hu, et al.
Published: (2018-05-01)

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
by: Lin Zhou, et al.
Published: (2015-11-01)

Egg White Ovotransferrin Attenuates RANKL-Induced Osteoclastogenesis and Bone Resorption
by: Nan Shang, et al.
Published: (2019-09-01)

LincRNA-Cox2 regulates IL6/JAK3/STAT3 and NF-κB P65 pathway activation in Listeria monocytogenes-infected RAW264.7 cells
by: Yurong Zhu, et al.
Published: (2021-07-01)

Role of nuclear factor kappa beta, tumor necrosis factor α, and cyclooxygenase-2 in preterm labor
by: Syamsul B. Riva'i, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_i4q8rfvcv7dvo56q5lie335b12